Immunic, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:IMUX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 40.87 M20.52 M61.43 M40.7 M24.05 M189.74 M 負債合計 22.44 M25.8 M27.52 M30.2 M30.73 M38.51 M 純資産合計 18.43 M-5.29 M33.91 M10.5 M-6.67 M151.23 M 負債および純資産合計 40.87 M20.52 M61.43 M40.7 M24.05 M189.74 M 有利子負債合計 —————— 純負債 ——————

ニュース

EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Immunic (NASDAQ:IMUX)

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)

Immunic: Saved By A 200 Million Private Placement (NASDAQ:IMUX)

アマゾン株、26%超上昇も？木曜日のトップアナリスト予想トップ10銘柄

Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested - TipRanks.com

What's Going On With Immunic Stock Friday? - Immunic (NASDAQ:IMUX)

Immunic, Inc. (IMUX) Presents at 8th Annual Neuroimmunology Drug Development Summit - Slideshow (NASDAQ:IMUX) 2026-04-16

Immunic stock initiated at Buy by Guggenheim on MS therapy potential

Immunic、Leerink Global Healthcare Conferenceで多発性硬化症治療薬の戦略的見解を提示

Immunic at Leerink Global Healthcare Conference: Strategic Insights on MS Drug

Immunic、ビドフルジムスカルシウムの投与法に関する欧州特許を取得

Immunic secures European patent for vidofludimus calcium dosing